Biotechnology company TriGemX Bio on Monday unveiled plans to go public by merging with special purpose acquisition company TCGX Acquisition Corp. in a deal built by five law firms that creates a combined company with a $600 million post-transaction equity value.
By Jade Martinez-Pogue ( October 19, 2026, 8:28 PM EDT) -- Biotechnology company TriGemX Bio on Monday unveiled plans to go public by merging with special purpose acquisition company TCGX Acquisition Corp. in a deal built by five law firms that creates a combined company with a $600 million post-transaction equity value....
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
And more!
Experience Law360 today with a free 7-day trial.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | 5 Firms Build Migraine-Focused TriGemX's $600M SPAC Deal | 0 | 13.33 | 19-10-2026 |
| 2 | 3 Firms Steer Cargo Drone Co.'s $800M SPAC Merger | 0 | 5 | 26-06-2026 |
| 3 | City Therapeutics' Upsized $200M IPO Joins Biotech Wave | 0 | 10.86 | 16-10-2026 |
| 4 | 5 Firms Steer $3.4B Silgan, Trivium Packaging Deal | 0 | 11.32 | 19-10-2026 |
| 5 | 3 Firms Guide Reusable Spacecraft Maker's $380M SPAC Deal | 0 | 11.7 | 06-08-2026 |
| 6 | Clean Energy Data Center Developer Inks $300M SPAC Merger | 0 | 11.59 | 09-10-2026 |
| 7 | 2 Firms Lead Merck's $11.3B Bio-Techne Life Sciences Deal | 0 | 7 | 25-06-2026 |
| 8 | United Therapeutics Buys Thymmune For Up To $300M | 0 | 5 | 02-07-2026 |
| 9 | Tarsus Bets Up To $800M On Alkeus In Retina Therapy Push | 0 | 10 | 06-08-2026 |
| 10 | BSTR Ends $1.5B SPAC Deal Amid Bitcoin Market Woes | 0 | 10.41 | 21-08-2026 |